Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12…
Rising to the Challenge: “Stop Sneeze to Wheeze” Takes on Allergic Rhinitis and Asthma with a Unified Approach
As millions around the world suffer from the debilitating effects of Allergic Rhinitis and its progression into Asthma, Alkem Laboratories Ltd. has taken a stand. Its recently launched “Stop Sneeze to Wheeze” initiative is poised to revolutionize how these conditions…
75% of Asthma Patients Have Worse Symptoms During Cold or Flu
Amid the ongoing cold waves of winters, smog and air pollution have resumed, thereby increasing the intensity of blocked airways in people’s lungs, giving a rise to respiratory problems. But everyone has only one set of lungs, which is integral…
11–14% of Children Aged 5 years & Older Currently Report Asthma Symptoms
Children are the most vulnerable and innocent members of the family and need special care and attention from elders. National Children’s Day highlights the need to raise awareness of children’s welfare and ensure a better future. On children’s day, Alkem…